Taiwan FDA registration 8156e48be85e269b3cfac9d8664894c8

"Nipro" Pholast balloon dilation catheter

TW: “尼普洛”汎司特球囊擴張導管

Taiwan·Risk Class 2·Goodman Co., Ltd. Goodman Research Center;; Goodman Co., Ltd.·Registered Dec 18, 2022 – Dec 18, 2027Active

Registration details

Analysis ID: 8156e48be85e269b3cfac9d8664894c8
Customs Code: DHA05603606809

Company information

Manufacturer: Goodman Co., Ltd. Goodman Research Center;; Goodman Co., Ltd.
Manufacturer Country: Japan
Authorized Representative: HORNG FWU PHARMA CO., LTD.

Product details

Intended Use: Details are as detailed as approved Chinese instructions
Product Type (Level 1): E Cardiovascular Medicine Science
Product Type (Level 2): E.1250 Percutaneous catheters
Import Information: import

Dates and status

Registration Date: Dec 18, 2022
Expiry Date: Dec 18, 2027

About this record

Access comprehensive regulatory information for "Nipro" Pholast balloon dilation catheter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8156e48be85e269b3cfac9d8664894c8 and manufactured by Goodman Co., Ltd. Goodman Research Center;; Goodman Co., Ltd.. The authorized representative in Taiwan is HORNG FWU PHARMA CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.